Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation
- PMID: 15284743
- DOI: 10.1016/j.ajog.2004.03.050
Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation
Abstract
Objective: This study was undertaken to determine maternal and perinatal outcomes after expectant management of severe preeclampsia between 24 and 33 weeks' gestation.
Study design: A prospective observational study of 239 women with severe preeclamptic and undelivered after antenatal steroid prophylaxis was performed. Pregnancy prolongation and maternal and perinatal morbidities were analyzed according to the gestational age at time of expectant management: 24 to 28, 29 to 31, and 32 to 33 weeks. Statistical analysis was performed by Student t test and chi(2) test.
Results: The days of pregnancy prolongation were significantly higher among those managed at less than 29 weeks (6) compared with the other groups (4). There were 13 perinatal deaths: 12 in those managed at less than 29 weeks and 1 in those managed at 29 to 31 weeks. Neonatal morbidities were significantly higher among those managed at less than 29 weeks compared with the other groups. There were no instances of maternal death or eclampsia. Maternal morbidities were similar among the groups.
Conclusion: Expectant management of severe preeclampsia at 24 to 33 weeks in a tertiary care center is associated with good perinatal outcome with a minimal risk for the mother.
Similar articles
-
Perinatal outcomes in severe preeclamptic women between 24-33(+6) weeks' gestation.J Med Assoc Thai. 2008 Jan;91(1):25-30. J Med Assoc Thai. 2008. PMID: 18386540
-
Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?Am J Obstet Gynecol. 2007 Mar;196(3):237.e1-5. doi: 10.1016/j.ajog.2006.10.905. Am J Obstet Gynecol. 2007. PMID: 17346535
-
Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.Arch Gynecol Obstet. 2005 Nov;273(1):43-9. doi: 10.1007/s00404-005-0741-3. Epub 2005 Apr 15. Arch Gynecol Obstet. 2005. PMID: 15834580
-
Expectant management in pregnancies with severe pre-eclampsia.Semin Perinatol. 2009 Jun;33(3):143-51. doi: 10.1053/j.semperi.2009.02.002. Semin Perinatol. 2009. PMID: 19464504 Review.
-
Management of pre-eclampsia remote from term.Eur J Obstet Gynecol Reprod Biol. 1991 Dec;42 Suppl:S96-101. Eur J Obstet Gynecol Reprod Biol. 1991. PMID: 1809618 Review.
Cited by
-
Administration of Antenatal Corticosteroids: Optimal Timing.Geburtshilfe Frauenheilkd. 2024 Jan 3;84(1):48-58. doi: 10.1055/a-2202-5363. eCollection 2024 Jan. Geburtshilfe Frauenheilkd. 2024. PMID: 38205043 Free PMC article.
-
Serum LDH Levels in Normotensive and Preeclamptic-Eclamptic Pregnant Women and Its Correlation With Fetomaternal Outcome.Cureus. 2023 Apr 6;15(4):e37220. doi: 10.7759/cureus.37220. eCollection 2023 Apr. Cureus. 2023. PMID: 37159784 Free PMC article.
-
Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis.Lancet Diabetes Endocrinol. 2022 Apr;10(4):243-252. doi: 10.1016/S2213-8587(22)00007-9. Epub 2022 Mar 4. Lancet Diabetes Endocrinol. 2022. PMID: 35255260 Free PMC article.
-
Outcomes following medical termination versus prolonged pregnancy in women with severe preeclampsia before 26 weeks.PLoS One. 2021 Feb 3;16(2):e0246392. doi: 10.1371/journal.pone.0246392. eCollection 2021. PLoS One. 2021. PMID: 33534858 Free PMC article.
-
Severe preterm preeclampsia: an examination of outcomes by race.Am J Obstet Gynecol MFM. 2020 Nov;2(4):100181. doi: 10.1016/j.ajogmf.2020.100181. Epub 2020 Jul 22. Am J Obstet Gynecol MFM. 2020. PMID: 33345907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical